Welcome to Stempeutics

Stempeutics Research Bangalore is a late stage life science company focused on developing and commercializing novel therapeutics based on adult stem cells. It was incorporated by the Manipal Group in Jan 2006 and entered into a strategic alliance with Cipla in 2009. Stempeutics strength lies in developing innovative stem cell products by nurturing cutting edge research and clinical applications through dedicated efforts of its highly qualified team.

Currently it is focussing on the following three innovative products: Stempeucel®, Stempeucare™ and Stempeutron™


In 2016 DCGI (Indian FDA) granted limited approval of Stempeucel® product sales for the treatment of CLI patients due to Buerger's disease. Stempeucel® is the FIRST innovative stem cell based biological product to be approved by DCGI for limited sales. Stempeutics has successfully put India on the global map for cutting edge drug discovery in the area of Stem Cells as Stempeucel® is one of the few stem cell products to be approved by a Regulatory body, anywhere in the world.


The company's lead product Stempeucel®, is ex-vivo cultured adult allogeneic mesenchymal stromal cells derived by using a novel pooling technology from multiple bone marrow donors and can be used as an 'off-the-shelf' cryopreserved stem cell product.
FIRST stem cell based biological product to be approved by DCGI for limited sales

It is an intensive firming skin care cosmetic product, branded as Cutisera. Cutisera product has 5 distinct benefits i.e. 
  (1) reduction of lines and wrinkles 
  (2) reduction / lightning of dark spots 
  (3) evenness of skin tone 
  (4) improvement in skin firmness 
  (5) Improvement in skin hydration.

It is an automated, point-of-care medical device for isolation of therapeutic stem and stromal cells from aspirated fat/adipose tissue. Adipose tissue stroma is a rich source of mesenchymal stem cells and endothelial progenitor cells, as well as other tissue-building cells such as vascular smooth muscle cells, pericytes, pre-adipocytes and fibroblasts.

US Patent Japan Patent India Bio